People

George Golumbeski

droiaventures.com

George Golumbeski is named Partner in Droia’s current public directory. The published professional background includes BA in Biology, University of Virginia; PhD in Genetics, University of Wisconsin-Madison; Novartis; Celgene (Bristol Myers Squibb); Arch Venture Partners; Board member Acceleron Pharma, Sage Therapeutics, Carrick Therapeutics, Shattuck Labs and others. This is a manager-published affiliation; advisory-board membership and Droia Labs scientific roles are qualified separately from the investment team. Exact appointment dates and personal cash participation are not inferred.